Enhanced expression of matrix metalloproteinase-3, -12, and -13 mRNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis.
Novartis Institute for Biomedical Research, Summit, New Jersey 07901, USA. arco.jeng@pharma.novartis.com
A Y
AY
Jeng
M
M
Chou
W K
WK
Sawyer
S L
SL
Caplan
J
J
Von Linden-Reed
M
M
Jeune
M F
MF
Prescott
D000818:Animals; D001057:Apolipoproteins E / Q000172:deficiency* / Q000235:genetics / Q000502:physiology; D001161:Arteriosclerosis / Q000201:enzymology* / Q000235:genetics; D017364:Collagenases / Q000235:genetics*; D004036:Diet, Atherogenic; D015971:Gene Expression Regulation, Enzymologic; D020022:Genetic Predisposition to Disease; D053508:Matrix Metalloproteinase 12; D053509:Matrix Metalloproteinase 13; D019278:Matrix Metalloproteinase 3 / Q000235:genetics*; D008666:Metalloendopeptidases / Q000235:genetics*; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000235:genetics; D014158:Transcription, Genetic
D001057:Apolipoproteins E; D012333:RNA, Messenger; D017364:Collagenases; D053509:Matrix Metalloproteinase 13; D008666:Metalloendopeptidases; C507081:Mmp13 protein, mouse; D019278:Matrix Metalloproteinase 3; D053508:Matrix Metalloproteinase 12